Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
74 hedge funds and large institutions have $86.1M invested in Vicarious Surgical in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 14 closing their positions.
608% more call options, than puts
Call options by funds: $92K | Put options by funds: $13K
150% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 12
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0.03% more ownership
Funds ownership: 1.45% → 1.48% (+0.03%)
6% less funds holding
Funds holding: 79 → 74 (-5)
15% less capital invested
Capital invested by funds: $102M → $86.1M (-$15.8M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.94M |
| 2 |
State Street
Boston,
Massachusetts
|
+$697K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$303K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$190K |
| 5 |
TFCP
Twin Focus Capital Partners
Boston,
Massachusetts
|
+$170K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$304K |
| 2 |
Jane Street
New York
|
-$171K |
| 3 |
TPWM
Twelve Points Wealth Management
Concord,
Massachusetts
|
-$133K |
| 4 |
Millennium Management
New York
|
-$131K |
| 5 |
WAM
Werlinich Asset Management
Stamford,
Connecticut
|
-$112K |
RBOT Hedge Fund Activity: Q2 2023 in Review
74 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2023, worth a combined $86.1M — down 15% from $102M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of RBOT and 10 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 30 added.
The largest buyer was BlackRock, adding an estimated $1.94M. The largest seller was Marshall Wace, cutting an estimated $304K.
- 74 institutional investors held Vicarious Surgical (RBOT) as of Q2 2023, down from 79 in Q1 2023.
- Funds reported $86.1M of Vicarious Surgical stock for Q2 2023, down 15% quarter-over-quarter.
- 10 funds opened new Vicarious Surgical positions in Q2 2023 and 14 closed out, a net change of -4 holders.
- The largest Vicarious Surgical buyer in Q2 2023 was BlackRock, an estimated $1.94M added.
- The largest Vicarious Surgical seller in Q2 2023 was Marshall Wace, an estimated $304K sold.
Based on aggregated 13F filings for Q2 2023.